Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

NCT01555138 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

581

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol
DRUG: Salmeterol

Sponsor

Novartis Pharmaceuticals